Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Esophageal Neoplasms × Electroporation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 18 Prostatic Neoplasms 8 Liver Neoplasms 6 Carcinoma, Hepatocellular 6 Neoplasm Metastasis 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Unresectable Pancreatic Cancer 2 Stomach Neoplasms 2 Neoplasms 2 Lymphatic Metastasis 2 Locally Advanced Pancreatic Cancer 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor Including Thyroid, Bone, Liver, Pancreas 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Adenocarcinoma Resectable 1 Melanoma 1 Liver, Cancer of, Non-Resectable 1 Liver Metastasis Colon Cancer 1 Laryngeal Neoplasms 1 Gynecological Cancers 1

Interventions

Cisplatin 97 Radiotherapy 91 Fluorouracil 81 Paclitaxel 70 Oxaliplatin 57 Docetaxel 54 Carboplatin 47 Irinotecan 39 Esophagectomy 38 Leucovorin 37 Surgical Procedures, Operative 34 Capecitabine 34 Radiation 31 Drug Therapy 25 Neoadjuvant Therapy 21 Cetuximab 17 Chemoradiotherapy 16 pembrolizumab 15 S 1 (combination) 15 Magnetic Resonance Spectroscopy 15 Bevacizumab 15 camrelizumab 14 Nivolumab 14 Blood Specimen Collection 13 Surveys and Questionnaires 12 Radiotherapy, Intensity-Modulated 11 Trastuzumab 10 Immunotherapy 10 Epirubicin 10 Endoscopic Mucosal Resection 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02430701 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡